e-learning
resources
Virtual 2021
06.09.2021
Back to infection basics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Analysis of volatile organic compounds in post-COVID-19 patients with eNose technology.
B. van Raaij (Leiden, Netherlands), J. Hameete (Leiden, Netherlands), J. Stöger (Leiden, Netherlands), M. Ninaber (Leiden, Netherlands), J. Geelhoed (Leiden, Netherlands)
Source:
Virtual Congress 2021 – Back to infection basics
Session:
Back to infection basics
Session type:
E-poster
Number:
2364
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. van Raaij (Leiden, Netherlands), J. Hameete (Leiden, Netherlands), J. Stöger (Leiden, Netherlands), M. Ninaber (Leiden, Netherlands), J. Geelhoed (Leiden, Netherlands). Late Breaking Abstract - Analysis of volatile organic compounds in post-COVID-19 patients with eNose technology.. 2364
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Comprehensive analysis of volatile organic compounds in human breath gas samples
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003
Late Breaking Abstract - Early exploratory use of omic approaches to assess metabolite changes in COPD
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020
Breath volatile organic compound (VOC) patterns in adult asthma patients of the ALLIANCE cohort
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Relationship between Volatile Organic Compounds (VOCs) in exhaled breath determined by Proton Transfer Reaction Time of Flight Mass Spectrometry (PTR-TOF-MS), clinical characteristics and airway inflammation in COPD
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Late Breaking Abstract - Differences in flavorant levels and synthetic coolant use between USA, EU and Canadian Juul products
Source: Virtual Congress 2020 – From tobacco and vaping health effects to tobacco cessation
Year: 2020
Interpretation of exhaled volatile organic compounds
Source: Eur Respir Monogr 2010; 49: 115-129
Year: 2010
Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Changes in exhaled volatile organic compound profile after breakfast: Implications for protocol development
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Late Breaking Abstract - Impact of an improvised system on preserving oxygen supplies in patients with COVID-19.
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Late Breaking Abstract - Capnography for ultimately simple diagnostics of COPD
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017
Airborne concentration of limonene (a volatile organic compound (VOC)), when using a spray of 41 essential oils
Source: Annual Congress 2013 –Outdoor and indoor environment: respiratory diseases from asthma to asbestosis
Year: 2013
The use of electronic nose technology for the detection of Lung Cancer (LC): analysis of exhaled volatile compounds by Aeonose®
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
Late Breaking Abstract - Development and validation of an automated radiomic CT signature for detecting?COVID-19
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020
Late Breaking Abstract - Exploring particles from exhaled air as a new source for protein biomarkers from the airways
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept